• 23410 Citations
  • 64 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joseph A. Sparano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Core Support for Cancer Center

    Bases, R., Kadish, A., Wiernik, P., Orr, G., Bloom, B., Shapiro, L., Lilly, F., Chase, J., Atkinson, P., Maio, J., Reid, L., Levine, W., Nathenson, S., Fant, J., Warner, J., Peisach, J., Horwitz, M., Krauter, K., Makman, M., Blumenfeld, O., Schulman, L., Klinger, H., Rajan, T., Wadler, S., Chance, M., Buhl, S., Desai, K., Pollard, J. W., Sparano, J. A., Hurwitz, J., Duran-Reynals, M., Serrano, L., Alderman, M., Shin, S., West, M., Birshstein, B., Marians, K., Eagle, H., Russel, R., Grills, G., Pickering, K., Mahmood, R., Keller, S. M., Herbst, L., Seither, R., Almo, S. C., Condeelis, J. S., Edelmann, W., Kucherlapati, R., Gupta, R., Depinho, R., Dutcher, J., Diamond, B., Gaertner, D. J., Keller, S. M., Pollard, J. W., Kucherlapati, R., Gupta, R., Depinho, R., Dutcher, J., Diamond, B., Gaertner, D. J. & Herbst, L. H.

    National Cancer Institute


    Project: Research project

  • AIDS Malignancy Clinical Trials Consortium

    Sparano, J. A., Vena, D., [No Value], J. Y., Ambinder, R. F., Levine, A., Dezube, B., Krown, S., Wachsman, W., Kaplan, L., Ramos, J. C., Stier, E., Aboulafia, D., Mitsuyasu, R., [No Value], J. Y., Krown, S., Wachsman, W., Kaplan, L., Harrington, W., [No Value], J. Y. & [No Value], J. Y.

    National Cancer Institute


    Project: Research project


    Sparano, J. A., Wiernik, P., Wiernek, P., Dutcher, J. & Wadler, S.

    National Cancer Institute


    Project: Research project

  • Publications

    Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In : npj Breast Cancer. 6, 1, 15.

    Research output: Contribution to journalReview article

    Open Access
  • 2 Scopus citations

    Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

    Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., Gartrell, B. A., Smith, R. V., Ohri, N., Garg, M., Racine, A. D., Kalnicki, S., Perez-Soler, R., Halmos, B. & Verma, A., Jul 1 2020, In : Cancer discovery. 10, 7, p. 935-941 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • Clinical Outcomes in Early Breast Cancer with a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

    Sparano, J. A., Gray, R. J., Makower, D. F., Albain, K. S., Saphner, T. J., Badve, S. S., Wagner, L. I., Kaklamani, V. G., Keane, M. M., Gomez, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Toppmeyer, D. L., Brufsky, A. M., Goetz, M. P., Berenberg, J. L., Mahalcioiu, C., Desbiens, C., Hayes, D. F. & 9 others, Dees, E. C., Geyer, C. E., Olson, J. A., Wood, W. C., Lively, T., Paik, S., Ellis, M. J., Abrams, J. & Sledge, G. W., Mar 2020, In : JAMA Oncology. 6, 3, p. 367-374 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 12 Scopus citations

    Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

    Wagner, L. I., Gray, R. J., Sparano, J. A., Whelan, T. J., Garcia, S. F., Yanez, B., Tevaarwerk, A. J., Carlos, R. C., Albain, K. S., Olson, J. A., Goetz, M. P., Pritchard, K. I., Hayes, D. F., Geyer, C. E., Dees, E. C., McCaskill-Stevens, W. J., Minasian, L. M., Sledge, G. W. & Cella, D., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1875-1886 12 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

    Pothuri, B., Brodsky, A. L., Sparano, J. A., Blank, S. V., Kim, M., Hershman, D. L., Tiersten, A., Kiesel, B. F., Beumer, J. H., Liebes, L. & Muggia, F., Apr 1 2020, In : Cancer Chemotherapy and Pharmacology. 85, 4, p. 741-751 11 p.

    Research output: Contribution to journalArticle